Rheumatoid arthritis trials recruiting in Pennsylvania

All Rheumatoid arthritis trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
  NCT06671054 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Duncansville
• A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
  NCT07412704 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
  NCT07137598 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Duncansville
• A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
  NCT07409103 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Duncansville, Wyomissing
• A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
  NCT06972446 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Duncansville
• Clinical Outcomes Study of the Nexel Total Elbow
  NCT02469662 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• ConsideRAte Study - Splenic Stimulation for RA
  NCT05003310 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Altoona
• Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
  NCT04528355 · Phase: Not specified · Ages: 2 Months to 60 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
  NCT02418442 · Phase: Not specified · Ages: Up to 21 Years · Sex: All (male and female) · Pennsylvania: Hershey, Philadelphia, Pittsburgh
• Phase 1b/2 Study of IV Sarilumab in Adult With RA
  NCT07704580 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Duncansville
• Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
  NCT07404865 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Duncansville, Willow Grove
• R-2487 in Patients With Rheumatoid Arthritis
  NCT05961592 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Duncansville
• RA-PRO PRAGMATIC TRIAL
  NCT04692493 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Duncansville, Exton, Pittsburgh, Wyomissing
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
  NCT01962415 · Phase: Phase 2 · Ages: 2 Months to 55 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Study of GS-0151 in Participants With Rheumatoid Arthritis
  NCT06902519 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Duncansville
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• The Myelin Disorders Biorepository Project
  NCT03047369 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh